跳至主要内容
临床试验/NCT07291739
NCT07291739已完成不适用

A Clinical Evaluation of a Phakic Intraocular Lens

Staar Surgical Company1 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2022年8月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
47
试验地点
1
主要终点
Change in visual acuity

研究概览

简要总结

The objective of this study is to evaluate the clinical performance of the STAAR EVO+ Visian™ Implantable Collamer® Lens with Aspheric (EDOF) Optic as refractive elements to correct or reduce myopia or hyperopia with presbyopia with or without astigmatism.

详细描述

This prospective, open-labeled, evaluation of clinical performance of the investigational EDOF and Toric EDOF (TEDOF) ICL will be conducted at a single site in the Philippines.

Up to 45-50 subjects (90 eyes) who meet all eligibility criteria will be assigned to one of the following treatment arms, as determined by their preoperative refraction and the Investigator's medical judgement:

  • EDOF Toric ICL in both eyes,
  • EDOF Toric ICL in one eye and EDOF spherical ICL in fellow eye,
  • EDOF spherical ICL in both eyes (up to 20 subjects/40 eyes).

Postoperatively, subjects will undergo ophthalmic examination at regular intervals per the study visit schedule up to 6 months after surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Require a spherical lens power from -18.00 Diopters to +3.00 Diopters in both eyes or (in case of EDOF Toric) additional cylindrical lens power between +1.0 to +3.0 Diopters of Cylinder.
  • Stable refractive history (+/-0.50 Diopters) as determined by manifest spherical equivalent.
  • Requires +1.00 Diopters to +2.50 Diopters reading add in both eyes.
  • Minimum distance corrected near visual acuity of 20/40 or worse in both eyes.
  • Other protocol-specified inclusion criteria may apply.

排除标准

  • History of previous ocular surgery.
  • Progressive sight threatening disease.
  • Low/abnormal endothelial cell density.
  • Monocular.
  • Serious acute non-ophthalmic disease.
  • Pregnant or nursing women, or those who plan to become pregnant over the course of the study.
  • Other protocol-specified exclusion criteria may apply.

结局指标

主要结局

Change in visual acuity

时间窗: 1 month, 3 months and 6 months postoperatively

Change from baseline in uncorrected distance, intermediate and near visual acuity and distance corrected near visual acuity

Change in refractive cylinder

时间窗: 1 month, 3 months and 6 months postoperatively

Change from baseline in absolute magnitude of subjective refractive cylinder

Lens axis misalignment

时间窗: 1 month, 3 months and 6 months postoperatively

Proportion of lenses with axis misalignment compared to operative day

Rotational stability

时间窗: 1 day, 1, week, 1 month, 3 months and 6 months postoperatively

Rotational stability by assessment of IOL axis meridian compared to placement on day of surgery

Compromise in visual acuity

时间窗: 6 months postoperatively

Clinically significant compromise in visual acuity based on subject questionnaires

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Clinical Evaluation of a Phakic Intraocular Lens | 临床试验